drugset / Trial / NCT00257686

Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients

NCT00257686

Phase 3 Completed 962 enrolled Kowa Research Europe
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of pitavastatin with that of pravastatin in elderly patients

Timeline

Start
2005-09
Primary completion
2006-05
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitavastatin Small molecule 1 mg
Subject Pitavastatin Small molecule 2 mg
Subject Pitavastatin Small molecule 4 mg
Comparator Pravastatin Small molecule 10 mg
Comparator Pravastatin Small molecule 20 mg
Comparator Pravastatin Small molecule 40 mg

Indications